13F HOLDINGS REPORT (Amended)
ACORN CAPITAL ADVISORS, LLC
Quarter ended Q1 2025 · Filed May 19, 2025 · Accession 0001636587-25-000021
Total Value
$149.9M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 1,131,501 | $27.7M | 18.49% |
| 2 | UROGEN PHARMA LTD | URGN | 1,516,303 | $16.8M | 11.18% |
| 3 | Y-MABS THERAPEUTICS INC | 984241109 | 3,235,387 | $14.3M | 9.56% |
| 4 | TREVI THERAPEUTICS INC | TRVI | 2,144,844 | $13.5M | 9.00% |
| 5 | CANDEL THERAPEUTICS INC | CADL | 2,152,252 | $12.2M | 8.11% |
| 6 | PUMA BIOTECHNOLOGY INC | PBYI | 3,940,052 | $11.7M | 7.78% |
| 7 | BICARA THERAPEUTICS | BCAX | 643,382 | $8.4M | 5.59% |
| 8 | PROTARA THERAPEUTICS INC | TARA | 1,279,800 | $5.5M | 3.64% |
| 9 | TERNS PHARMACEUTICALS INC | TERN | 1,971,264 | $5.4M | 3.63% |
| 10 | ONKURE THERAPEUTICS INC | OKUR | 1,439,674 | $5.1M | 3.42% |
| 11 | VERASTEM INC | VSTM | 779,498 | $4.7M | 3.13% |
| 12 | CYBIN INC | HELP | 734,394 | $4.7M | 3.11% |
| 13 | CARDIF ONCOLOGY INC | CRDF | 1,442,308 | $4.5M | 3.02% |
| 14 | OPTINOSE INC | 68404V209 | 422,814 | $3.9M | 2.59% |
| 15 | WHITEHAWK THERAPEUTICS INC | WHWK | 1,139,363 | $2.0M | 1.35% |
| 16 | X4 PHARMACEUTICALS INC | XFOR | 7,310,650 | $1.8M | 1.17% |
| 17 | MURAL ONCOLOGY PLC | G63365103 | 1,269,715 | $1.6M | 1.07% |
| 18 | AURA BIOSCIENCES INC | AURA | 590,508 | $1.5M | 0.97% |
| 19 | BIOATLA INC | BCAB | 4,032,046 | $1.4M | 0.94% |
| 20 | Q32 BIO INC. | QTTB | 803,425 | $1.3M | 0.88% |
| 21 | VYNE THERAPEUTICS INC | VYNE | 785,938 | $1.2M | 0.83% |
| 22 | ACRIVON THERAPEUTICS INC | ACRV | 405,237 | $822,632 | 0.55% |